In a move to address the high cost of prescription drugs, President Trump has announced pricing deals with nine major pharmaceutical companies. These deals will allow Medicaid and consumers to purchase certain drugs at discounted prices. The companies involved in the agreements include Merck, Eli Lilly, Amgen, Pfizer, Novartis, Sanofi, Bristol-Myers Squibb, AstraZeneca, and Gilead Sciences. The president stated that these deals are part of his administration's ongoing efforts to lower drug prices and make healthcare more affordable for Americans. Additionally, Trump revealed that he plans to initiate similar negotiations with health insurance providers in the near future. This suggests a broader strategy to tackle the issue of rising healthcare costs from multiple angles, involving both drug manufacturers and insurance companies. The announcement comes amid growing concerns over the affordability of prescription drugs, which have been a significant burden for many individuals and families. The administration's efforts to address this problem are seen as a step towards making healthcare more accessible and improving the overall well-being of the American public.
Dec 19, 2025 → Dec 31, 2025
The US Appeals Court has ruled in favor of the Trump administration's decision to strip Medicaid funding from Planned Parenthood health centers in 22 states and Washington DC. The court reversed an earlier injunction issued by a US…
Read original at The Guardian →3 updates from 2 sources over 12 days.
The US Appeals Court has ruled in favor of the Trump administration's decision to strip Medicaid funding from Planned Parenthood health centers in 22 states and Washington DC. The court reversed an earlier injunction…
Read original at The Guardian →The article discusses the high drug prices in the United States and disputes the claim made by former President Donald Trump that other Western countries are to blame. The authors, Susi Geiger and Théo Bourgeron, argue…
Read original at The Guardian →In a move to address the high cost of prescription drugs, President Trump has announced pricing deals with nine major pharmaceutical companies. These deals will allow Medicaid and consumers to purchase certain drugs at…
Read original at NYT →What this story stands on. Tier 0 is a primary record or the subject's own words; higher tiers must be attributed, never stated as bare fact.
The US Appeals Court has ruled in favor of the Trump administration's decision to strip Medicaid funding from Planned Parenthood health centers in 22 states and Washington DC. The court reversed an earlier injunction issued by a US…
View source →The article discusses the high drug prices in the United States and disputes the claim made by former President Donald Trump that other Western countries are to blame. The authors, Susi Geiger and Théo Bourgeron, argue that pharmaceutical…
View source →In a move to address the high cost of prescription drugs, President Trump has announced pricing deals with nine major pharmaceutical companies. These deals will allow Medicaid and consumers to purchase certain drugs at discounted prices.…
View source →Tier key: T0 = Primary source · T1 = Wire · T2 = Outlet report · T3 = Commentary
Long-running fight over Trump-backed maps takes another turn as absentee voting is already under way in Missouri. This blog is now closed. Sign up for US Breaking News emails Xi…
This new task force is Trump's latest response to the debate over AI safety.
The Trump administration’s decision to revoke the visa of a Peruvian judge who sided with a Chinese company in a port dispute puts a new spotlight on the growing US-China rivalry…
As Bosnians vote in an election this weekend, the country is embracing the US president’s family and friends.
On Equity, we discussed the Trump administration's attempts to rebrand AI.
Donald Trump and Xi Jinping discuss Taiwan arms sales every time they get together but the American stance on the self-ruled island remains unchanged following the Chinese…
